Prescription drug · NDA
Radiogardase (prussian blue insoluble capsules) NDC 58060-002
Ferric ferrocyanide 500 mg/1 · Capsule · Oral · Heyl Chem.-pharm. Fabrik GmbH & Co. KG
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58060-002-02 | 58060000202 | 1 BOTTLE, PLASTIC in 1 CARTON (58060-002-02) / 36 CAPSULE in 1 BOTTLE, PLASTICMarketed from Mar 24, 2010 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Radiogardase
- Generic name (nonproprietary)
- prussian blue insoluble capsules
- Active ingredients
- Ferric ferrocyanide — 500 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021626
- Marketing start
- Listing expires
- Other FDA classes
- Chelating Activity (Mechanism)Ion Exchange Activity (Mechanism)
- Identifiers
- Product ID 58060-002_cdc03368-9c60-d716-e053-2995a90a0963SPL ID cdc03368-9c60-d716-e053-2995a90a0963SPL set ID baa68c79-5f3d-468a-a510-58b9e978cd50RxCUI 759006, 759009UNII TLE294X33A
- Pharmacologic class
- Decorporation Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N458060000202followed by a unit qualifier and the quantityPackage 58060-0002-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Radiogardase is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium, in order to increase their rates of elimination. Radiogardase is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination. ( 1 )
Excerpt only. Read the full label for complete information.